5/23/2013

Although Japan is the world's second-largest pharmaceutical market after the U.S., generics represent only 6.6% of prescription drug sales, largely because of public attitudes skeptical of the effectiveness and safety of unfamiliar brands, especially if the drugs are produced in countries such as India and China. Several factors may help change these views: government efforts to further cut generic-drug prices, higher reimbursements for generics, patent expirations and a rapidly aging population.

Full Story:
BioSpectrum Asia

Related Summaries